Can you maybe just talk about how discussions with pharma customers have been trending so far this year, particularly as interest in AI appears to be evolving? And I am curious where de-identified ...
Management stated that these milestones further validate the potential benefits of nsPFA and increase awareness of the ...
Good morning, and welcome to Ocugen First Quarter 2026 Financial Results and Business Update. [Operator Instructions] I will now turn the call over to Tiffany Hamilton, Ocugen's Head of Corporate ...
Good morning, and thank you for joining us for the Neuronetics First Quarter 2026 Conference Call. Joining me on today's call is Neuronetics ...
Thank you, Trip. At Pulse Biosciences, we aren't just making a better medical device, we are creating a pulsed field ablation platform to completely shift how physicians treat disease.
Commercial Cell and Gene Therapy Revenue -- $9.1 million, up 26% year over year, reflecting growth in therapies supported.
Predicting the outcome of mental health therapy is a vital goal. Statistical models have been used. Now, we turn to using AI ...
Operator: Good day, and thank you for standing by. Welcome to Q1 2026 Grand Canyon Education, Inc. earnings conference call.
Bahrain Moments on MSN
How AI is transforming marriage counseling services today
AI is transforming marriage counseling by making therapy more accessible, efficient, and personalized. From AI chatbots to ...
Dr. Maryam Lustberg discusses the REVITALIZE trial testing CO2 laser therapy to treat vaginal dryness and GSM in breast ...
Total Revenue -- $164.9 million, up from $157.2 million the previous year; reflects increasing prescriptions and patient volume. Prescription Trends -- Record levels of new prescriptions, new patient ...
Operator: Thank you for standing by, and welcome to Corcept Therapeutics First Quarter 2026 Earnings Conference Call.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results